Orleans Capital Management Corp LA trimmed its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 76.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,082 shares of the pharmacy operator’s stock after selling 13,097 shares during the quarter. Orleans Capital Management Corp LA’s holdings in Walgreens Boots Alliance were worth $296,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also recently bought and sold shares of WBA. Hudock Capital Group LLC raised its stake in Walgreens Boots Alliance by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 6 shares during the period. Westside Investment Management Inc. raised its stake in shares of Walgreens Boots Alliance by 10.4% in the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 125 shares during the last quarter. Zions Bancorporation raised its stake in shares of Walgreens Boots Alliance by 983.3% in the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 1,239 shares during the last quarter. IHT Wealth Management LLC raised its stake in shares of Walgreens Boots Alliance by 46.3% in the second quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock worth $135,000 after purchasing an additional 2,199 shares during the last quarter. Finally, Bristlecone Advisors LLC purchased a new stake in shares of Walgreens Boots Alliance in the third quarter worth approximately $135,000. 60.82% of the stock is currently owned by institutional investors and hedge funds.
In other news, insider Stefano Pessina acquired 98,858 shares of Walgreens Boots Alliance stock in a transaction on Monday, January 15th. The stock was acquired at an average cost of $76.07 per share, with a total value of $7,520,128.06. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 14.80% of the company’s stock.
Several analysts have recently commented on WBA shares. Pivotal Research lowered their price objective on Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating for the company in a research note on Tuesday, October 24th. Deutsche Bank started coverage on Walgreens Boots Alliance in a research note on Monday, December 4th. They issued a “hold” rating and a $78.00 price objective for the company. Vetr raised Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, December 12th. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $82.00 price objective for the company in a research note on Saturday, January 13th. Finally, Jefferies Group set a $93.00 price objective on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Sunday, October 29th. Ten investment analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $85.37.
Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $70.91 on Wednesday. The stock has a market capitalization of $70,250.00, a P/E ratio of 19.59, a PEG ratio of 1.19 and a beta of 1.18. The company has a quick ratio of 0.47, a current ratio of 0.96 and a debt-to-equity ratio of 0.48. Walgreens Boots Alliance Inc has a twelve month low of $63.82 and a twelve month high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.01. The company had revenue of $30.74 billion during the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. Walgreens Boots Alliance’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period in the prior year, the company posted $1.10 earnings per share. analysts anticipate that Walgreens Boots Alliance Inc will post 5.73 EPS for the current year.
Walgreens Boots Alliance declared that its Board of Directors has authorized a stock repurchase plan on Wednesday, October 25th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the pharmacy operator to purchase shares of its stock through open market purchases. Shares buyback plans are usually an indication that the company’s management believes its shares are undervalued.
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 12th. Stockholders of record on Thursday, February 15th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.26%. The ex-dividend date is Wednesday, February 14th. Walgreens Boots Alliance’s dividend payout ratio is presently 44.20%.
TRADEMARK VIOLATION WARNING: This story was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://www.dispatchtribunal.com/2018/02/21/walgreens-boots-alliance-inc-wba-stake-lessened-by-orleans-capital-management-corp-la.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.